Psychiatry & Neurology Doctors in Flourtown, PA Accepting Medicare

2 Psychiatry & Neurology doctors found. Showing 1 - 2

Doreen Thomas-payne, Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 1811 Bethlehem Pike Unit A102, Flourtown, PA 19031 Phone: 215-948-3171

James Michael Delaplane, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 12 E Mill Rd, Flourtown, PA 19031 Phone: 215-767-4390    Fax: 267-331-9485

News Archive

Breakthrough research to be presented at AAO-HNSF 2015 Annual Meeting & OTO EXPO

Research to be presented tomorrow at the 2015 Annual Meeting & OTO EXPOSM of the American Academy of Otolaryngology-Head and Neck Surgery Foundation (AAO-HNSF) spans across the otolaryngology specialty.

Scientists discover new genetic mutation for amyotrophic lateral sclerosis

A team led by scientists from Johns Hopkins and the National Institutes of Health has discovered a new genetic mutation for amyotrophic lateral sclerosis (ALS) and a related disease called frontotemporal dementia (FTD) that appears to account for more than a third of all inherited cases of these diseases.

NUS, Washington University jointly open new research institute to address social challenges

The National University of Singapore Faculty of Arts and Social Sciences has partnered the Washington University in St. Louis to set up a dedicated research institute - the Next Age Institute (NAI) - to study, design and test social innovations to address complex social issues surrounding families, communities and societies in Singapore and around the world.

Research: Mediterranean diet linked to lower risk of diabetes

Adoption of a Mediterranean diet is linked to a lower risk of diabetes, especially among people at high risk for cardiovascular disease, according to research to be presented at the American College of Cardiology's 63rd Annual Scientific Session.

AGTC, Icagen complete agreement for purchase and sale of patent rights

AGTC, a privately held company, and Icagen, Inc. today announced the completion of an agreement for the purchase and sale of certain patent rights between the companies. Icagen is transferring its rights to patents relating to the ion channel gene CNGB3, which has been linked to certain disorders of the eye. Under the terms of the agreement, Icagen has assigned ownership of the patents to AGTC, which intends to use the patented technology for gene therapy as a potential treatment for Achromatopsia, a severe form of daytime blindness.

Read more Medical News

› Verified 2 days ago